Cargando…
Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma
BACKGROUND: A 24-year-old female patient was diagnosed with classic Hodgkin's lymphoma in clinical stage II, and combination chemotherapy followed by radiotherapy was initiated. During the following 5 years, the disease progressed despite several standard therapeutic approaches, including autol...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893445/ https://www.ncbi.nlm.nih.gov/pubmed/20509896 http://dx.doi.org/10.1186/1756-8722-3-20 |